Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TNFRSF4 Antikörper

TNFRSF4 Reaktivität: Human, Non-Human Primate WB, FACS, ELISA, IP, IHC (fro), IHC (p) Wirt: Maus Monoclonal Ber-ACT35 unconjugated
Produktnummer ABIN2749179
  • Target Alle TNFRSF4 Antikörper anzeigen
    TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
    Reaktivität
    • 68
    • 53
    • 34
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    Human, Non-Human Primate
    Wirt
    • 56
    • 37
    • 17
    • 2
    Maus
    Klonalität
    • 57
    • 53
    Monoklonal
    Konjugat
    • 54
    • 12
    • 11
    • 8
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TNFRSF4 Antikörper ist unkonjugiert
    Applikation
    • 60
    • 53
    • 31
    • 16
    • 14
    • 13
    • 11
    • 10
    • 9
    • 8
    • 6
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Flow Cytometry (FACS), ELISA, Immunoprecipitation (IP), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Spezifität
    The mouse monoclonal antibody Ber-ACT35 (also known as ACT35) recognizes an extracellular epitope of CD134 (TNFRSF4, OX40), an approximately 50 kDa type I transmembrane glycoprotein expressed on activated T cells.
    Kreuzreaktivität (Details)
    Human, Non-Human Primates
    Aufreinigung
    Purified by protein-A affinity chromatography.
    Reinheit
    > 95 % (by SDS-PAGE)
    Immunogen
    HTLV 1-transformed HUT-102 cells
    Klon
    Ber-ACT35
    Isotyp
    IgG1 kappa
    Top Product
    Discover our top product TNFRSF4 Primärantikörper
  • Applikationshinweise
    Flow cytometry: Recommended dilution: 3-6 μg/mL.
    Immunohistochemistry: Recommended dilution: 5-10 μg/mL.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1 mg/mL
    Buffer
    Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store at 2-8°C. Do not freeze.
  • Voo, Bover, Harline, Vien, Facchinetti, Arima, Kwak, Liu: "Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 191, Issue 7, pp. 3641-50, (2013) (PubMed).

    Tanijiri, Shimizu, Uehira, Yokoi, Amuro, Sugimoto, Torii, Tajima, Ito, Amakawa, Fukuhara: "Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells." in: Journal of leukocyte biology, Vol. 82, Issue 3, pp. 576-84, (2007) (PubMed).

    Willett, McMonagle, Ridha, Hosie: "Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus." in: Journal of virology, Vol. 80, Issue 7, pp. 3386-94, (2006) (PubMed).

    Li, Zhang: "The effect of anti-human CD134 monoclonal antibody on phytohemagglutinin-induced mRNA expression of perforin in peripheral blood mononuclear cells." in: Cellular & molecular immunology, Vol. 2, Issue 6, pp. 467-71, (2006) (PubMed).

    Endl, Rosinger, Schwarz, Friedrich, Rothe, Karges, Schlosser, Eiermann, Schendel, Boehm: "Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes." in: Diabetes, Vol. 55, Issue 1, pp. 50-60, (2005) (PubMed).

    Aten, Roos, Claessen, Schilder-Tol, Ten Berge, Weening: "Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis." in: Journal of the American Society of Nephrology : JASN, Vol. 11, Issue 8, pp. 1426-38, (2000) (PubMed).

    Jones, Fletcher, Pulford, Shahsafaei, Dorfman: "The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma." in: Blood, Vol. 93, Issue 10, pp. 3487-93, (1999) (PubMed).

  • Target
    TNFRSF4 (Tumor Necrosis Factor Receptor Superfamily, Member 4 (TNFRSF4))
    Andere Bezeichnung
    CD134 (TNFRSF4 Produkte)
    Synonyme
    TNFRSF4 antikoerper, ACT35 antikoerper, CD134 antikoerper, Ly-70 antikoerper, Ox40 antikoerper, TXGP1L antikoerper, Txgp1 antikoerper, OX40 antikoerper, TNF receptor superfamily member 4 antikoerper, tumor necrosis factor receptor superfamily, member 4 antikoerper, TNFRSF4 antikoerper, Tnfrsf4 antikoerper
    Hintergrund
    TNF receptor superfamily member 4,CD134 (TNFRSF4, also known as OX40) is a type I transmembrane glycoprotein of TNF/NGF receptor family expressed on activated T cells, fibroblasts, and hematopoietic precursors. Binding to its ligand (OX40L, TNFSF4) on antigen presenting cells gives to the T cell costimulatory signal, and this interaction results also in B cell proliferation and influences T cell memory pool. CD134 is upregulated at sites of inflammation, especially in case of multiple sclerosis and psoriatic lesions.,TNFRSF4, OX40, ACT35, IMD16, TXGP1L
    Gen-ID
    7293
    UniProt
    P43489
    Pathways
    Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints
Sie sind hier:
Kundenservice